This federal contract award was made by the Federal Medical Center Rochester, a civilian agency, to the prime contractor Mckesson Corporation, doing business as Mckesson. The $7,550.62 firm fixed price purchase order is for the delivery of FY25 B1 McKesson open market pharmaceutical products from February 24, 2024 to February 28, 2025. No set-aside designation was used.
Mckesson is a healthcare services and information technology company that has provided a range of pharmaceutical products and services to various federal agencies, including the Department of Justice's Bureau of Prisons, the Department of Veterans Affairs, the Department of Health and Human Services' Indian Health Service, and the Peace Corps. These deliveries have included HIV medications, specialty pharmaceuticals, medication-assisted treatment drugs, COVID-19 vaccines, and other medical consumables. Mckesson also holds a single-award blanket purchase agreement with the Indian Health Service, valued at up to $710 million over seven years, to provide pharmaceutical products not available through the VA's broader prime vendor program.
Generated 2/28/25, 9:51 AM